The antibody response to influenza vaccination is not impaired in type 2 diabetics

Vaccine

Volumn 33, Issue 29, 2015, Pages 3306-3313

  Sheridan, Patricia A ^a   Paich, Heather A ^a   Handy, Jean ^b   Karlsson, Erik A ^c   Schultz Cherry, Stacey ^c   Hudgens, Michael ^d   Weir, Sam ^b   Noah, Terry ^b   Beck, Melinda A ^a  

^a University of North Carolina   (United States)

^b UNIVERSITY OF NORTH CAROLINA SCHOOL OF MEDICINE   (United States)

^c ST JUDE CHILDREN S RESEARCH HOSPITAL   (United States)

^d University of North Carolina at Chapel Hill   (United States)

Author keywords

Antibody and immune response; Diabetes; Influenza vaccine; Obesity

Indexed keywords

INFLUENZA VACCINE; VIRUS ANTIBODY;

ADULT; AGED; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BODY HEIGHT; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION; HUMAN; IMMUNE RESPONSE; IMMUNOSUPPRESSIVE TREATMENT; INFLUENZA VACCINATION; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; OBESITY; OBSERVATIONAL STUDY; PRIORITY JOURNAL; PROSPECTIVE STUDY; SEROCONVERSION; VERY ELDERLY; ADOLESCENT; ANTIBODY PRODUCTION; BLOOD; HEMAGGLUTINATION INHIBITION TEST; IMMUNOLOGY; MIDDLE AGED; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; ANTIBODIES, VIRAL; ANTIBODY FORMATION; DIABETES MELLITUS, TYPE 2; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HEMAGGLUTINATION INHIBITION TESTS; HUMANS; INFLUENZA VACCINES; MALE; MIDDLE AGED; PROSPECTIVE STUDIES; YOUNG ADULT;

EID: 84931573816     PISSN: 0264410X     EISSN: 18732518     Source Type: Journal    
DOI: 10.1016/j.vaccine.2015.05.043     Document Type: Article

References (26)

1. Flegal K.M., Carroll M.D., Ogden C.L. Prevalence and trends in obesity among US adults, 1999-2008. JAMA 2010, 303:235-241.
2. Centers for Disease Control (US) National diabetes statistics report 2014, 〈http://wwwcdcgov/diabetes/pdfs/data/2014-report-estimates-of-diabetes-and-its-burden-in-the-united-statespdf〉.
3. Karlsson E.A., Beck M.A. The burden of obesity on infectious disease. Exp Biol Med (Maywood) 2010, 235:1412-1424.
4. Thompson M.G., Shay D.K., Zhou H., Bridges C.B., Cheng P.Y., Burns E., et al. Estimates of deaths associated with seasonal influenza-United States, 1976-2007. Morb Mortal Wkly Rep 2010, 59:1057-1062.
5. Allard R., Leclerc P., Tremblay C., Tannenbaum T.N. Diabetes and the severity of pandemic influenza A (H1N1) infection. Diabetes Care 2010, 33:1491-1493.
6. Louie J.K., Acosta M., Winter K., Jean C., Gavali S., Schechter R., et al. Factors associated with death or hospitalization due to pandemic 2009 influenza A(H1N1) infection in California. JAMA 2009, 302:1896-1902.
7. Kumar A., Zarychanski R., Pinto R., Cook D.J., Marshall J., Lacroix J., et al. Critically ill patients with 2009 influenza A(H1N1) infection in Canada. JAMA 2009, 302:1872-1879.
8. Sheridan P.A., Paich H.A., Handy J., Karlsson E.A., Hudgens M.G., Sammon A.B., et al. Obesity is associated with impaired immune response to influenza vaccination in humans. Int J Obes (Lond) 2012, 36:1072-1077.
9. Centers for Disease Control (US) People at high risk of developing flu-related complications 2013, 〈http://wwwcdcgov/flu/about/disease/high_riskhtm〉.
10. Hong K.W., Cheong H.J., Choi W.S., Lee J., Wie S.H., Baek J.H., et al. Clinical courses and outcomes of hospitalized adult patients with seasonal influenza in Korea, 2011-2012: Hospital-based Influenza Morbidity & Mortality (HIMM) surveillance. J Infect Chemother 2014, 20:9-14.
11. Schillie S.F., Spradling P.R., Murphy T.V. Immune response of hepatitis B vaccine among persons with diabetes: a systematic review of the literature. Diabetes Care 2012, 35:2690-2697.
12. Patriarca P.A., Kendal A.P., Stricof R.L., Weber J.A., Meissner M.K., Dateno B. Influenza vaccination and warfarin or theophylline toxicity in nursing-home residents. N Engl J Med 1983, 308:1601-1602.
13. Poli D., Chiarugi L., Capanni M., Antonucci E., Abbate R., Gensini G.F., et al. Need of more frequent International Normalized Ratio monitoring in elderly patients on long-term anticoagulant therapy after influenza vaccination. Blood Coagul Fibrinolysis 2002, 13:297-300.
14. Palmer D.F., Dowle W., Coleman M.T., Schild G.C. Haemagglutination-inhibition test, advanced laboratory techniques for influenza diagnosis 1975, US Department of Health, Education and Welfare, Public Health Service, Center for Disease Control, Atlanta, GA.
15. Luytjes W., Enouf V., Schipper M., Gijzen K., Liu W.M., van der Lubben M., et al. HI responses induced by seasonal influenza vaccination are associated with clinical protection and with seroprotection against non-homologous strains. Vaccine 2012, 30:5262-5269.
16. Team RDC R. A language and environment for statistical computing 2011, R Foundation for Statistical Computing, Vienna, Austria.
17. Assoc A.D. Standards of medical care in diabetes-2011 American Diabetes Association. Diabetes Care 2011, 34:S11-S61.
18. Paich H.A., Sheridan P.A., Handy J., Karlsson E.A., Schultz-Cherry S., Hudgens M.G., et al. Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza a virus. Obesity (Silver Spring) 2013, 21:2377-2386.
19. Xie H., Jing X., Li X., Lin Z., Plant E., Zoueva O., et al. Immunogenicity and cross-reactivity of 2009-2010 inactivated seasonal influenza vaccine in US adults and elderly. PLoS ONE 2011, 6:e16650.
20. Nam J.S., Kim A.R., Yoon J.C., Byun Y., Kim S.A., Kim K.R., et al. The humoral immune response to the inactivated influenza A (H1N1) 2009 monovalent vaccine in patients with Type 2 diabetes mellitus in Korea. Diabet Med 2011, 28:815-817.
21. Frasca D., Diaz A., Romero M., Mendez N.V., Landin A.M., Ryan J.G., et al. Young and elderly patients with type 2 diabetes have optimal B cell responses to the seasonal influenza vaccine. Vaccine 2013, 31:3603-3610.
22. Prevention CfDCa National diabetes fact sheet: national estimates and general information on diabetes and prediabetes in the United States, 2011 2011, 12. Atlanta, GA, 〈http://wwwcdcgov/diabetes/pubs/pdf/ndfs_2011pdf〉. U.S. Department of Health and Human Services CfDCaP (Ed.).
23. Louie J.K., Acosta M., Samuel M.C., Schechter R., Vugia D.J., Harriman K., et al. A novel risk factor for a novel virus: obesity and 2009 pandemic influenza A (H1N1). Clin Infect Dis 2011, 52:301-312.
24. Ganatra R.B., McKenna J.J., Bramley A.M., Skarbinski J., Fry A.M., Finelli L., et al. Adults with diabetes hospitalized with pandemic influenza A(H1N1)pdm09-U.S. 2009. Diabetes Care 2013, 36:e94.
25. Lau D., Eurich D.T., Majumdar S.R., Katz A., Johnson J.A. Effectiveness of influenza vaccination in working-age adults with diabetes: a population-based cohort study. Thorax 2013, 68:658-663.
26. Michiels B., Govaerts F., Remmen R., Vermeire E., Coenen S. A systematic review of the evidence on the effectiveness and risks of inactivated influenza vaccines in different target groups. Vaccine 2011, 29:9159-9170.